Joint (NASDAQ:JYNT) Price Target Lowered to $50.00 at Lake Street Capital

Joint (NASDAQ:JYNTGet Rating) had its price objective lowered by equities research analysts at Lake Street Capital from $100.00 to $50.00 in a note issued to investors on Friday, The Fly reports. Lake Street Capital’s target price would indicate a potential upside of 222.37% from the stock’s current price.

Other analysts have also issued reports about the stock. B. Riley lowered shares of Joint from a “buy” rating to a “neutral” rating in a research report on Friday. Craig Hallum lowered shares of Joint from a “buy” rating to a “hold” rating and dropped their price target for the stock from $90.00 to $30.00 in a research report on Friday. Zacks Investment Research upgraded shares of Joint from a “sell” rating to a “hold” rating in a report on Thursday, April 28th. DA Davidson decreased their price objective on shares of Joint from $128.00 to $69.00 and set a “buy” rating on the stock in a report on Friday, February 25th. Finally, StockNews.com downgraded shares of Joint from a “hold” rating to a “sell” rating in a report on Saturday, April 30th. One analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Joint currently has a consensus rating of “Hold” and a consensus target price of $67.00.

Shares of JYNT stock traded down $12.52 during trading on Friday, reaching $15.51. The company’s stock had a trading volume of 69,118 shares, compared to its average volume of 275,123. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 0.07. The business has a fifty day moving average price of $34.22 and a 200-day moving average price of $56.20. Joint has a one year low of $27.17 and a one year high of $111.06. The company has a market cap of $224.27 million, a price-to-earnings ratio of 31.94 and a beta of 1.31.

Joint (NASDAQ:JYNTGet Rating) last posted its quarterly earnings results on Thursday, May 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.05). Joint had a return on equity of 26.30% and a net margin of 8.82%. During the same quarter in the prior year, the business earned $0.16 EPS. Research analysts anticipate that Joint will post 0.33 EPS for the current year.

In other Joint news, CFO Jake Singleton purchased 1,515 shares of the firm’s stock in a transaction that occurred on Wednesday, March 16th. The shares were acquired at an average cost of $33.00 per share, for a total transaction of $49,995.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Peter D. Holt purchased 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 16th. The stock was acquired at an average price of $33.24 per share, for a total transaction of $49,860.00. The disclosure for this purchase can be found here. Corporate insiders own 6.10% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of JYNT. Captrust Financial Advisors lifted its position in Joint by 117.6% during the third quarter. Captrust Financial Advisors now owns 285 shares of the company’s stock worth $28,000 after purchasing an additional 154 shares during the period. Pinebridge Investments L.P. bought a new stake in Joint during the fourth quarter worth about $33,000. Point72 Hong Kong Ltd bought a new stake in Joint during the fourth quarter worth about $36,000. Marshall Wace North America L.P. bought a new stake in Joint during the first quarter worth about $47,000. Finally, PNC Financial Services Group Inc. lifted its position in Joint by 73.3% during the third quarter. PNC Financial Services Group Inc. now owns 629 shares of the company’s stock worth $62,000 after purchasing an additional 266 shares during the period. 86.39% of the stock is owned by institutional investors and hedge funds.

Joint Company Profile (Get Rating)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.

Featured Stories

The Fly logo

Analyst Recommendations for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.